Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-25-029721
Filing Date
2025-06-05
Accepted
2025-06-05 17:03:46
Documents
3
Period of Report
2025-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1749157404.html 3  
1 FORM 3 wk-form3_1749157404.xml 3 1650
2 EX-24 powerofattorney-tcoughli.htm EX-24 644
3 powerofattorney-tcoughli001.jpg GRAPHIC 126987
  Complete submission text file 0001628280-25-029721.txt   178818
Mailing Address 339 NORTH GRANADOS AVE SOLANA BEACH CA 92075
Business Address
COUGHLIN TIMOTHY (Reporting) CIK: 0001376043 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39071 | Film No.: 251027982

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Issuer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)